K

Korrobio

5 open positions
Last updated Oct 27, 2026
1-10 employees
Remote0%
Hybrid57%
On-site43%
Salary shown100%
Avg. listing99d
This month3 new · 1 closed

Associate Medical Director / Medical Director

$175k–$250k/year
42
Low

Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing p

OtherHealthcareMedical DirectorPhysicianFull-TimeExecutive
See 4 similar>
4 0 0 17d ago

Associate Director, Clinical Quality Assurance

$190k–$220k/year
37
Lowest

Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing p

OtherQuality AssuranceFull-TimeExecutive
See 2 similar>
5 0 0 25d ago

Senior Scientist

$160k–$180k/year
34
Lowest

Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing p

OtherScientistFull-TimeSenior
See 2 similar>
4 0 0 25d ago

Associate Director, Data Manager

$185k–$220k/year
37
Lowest

Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing p

DataData ManagerFull-TimeExecutive
See 2 similar>
5 0 0 1mo ago

Senior Clinical Trial Manager

$163k–$187k/year
35
Lowest

Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing p

HealthcareClinical ResearcherFull-TimeSenior
See 2 similar>
4 0 0↻ Repost 1mo ago